Duke University: Coronary Artery Disease trials
The registry lists 10 Coronary Artery Disease studies with Duke University as lead sponsor. 1 are open to participants now and 3 have results posted.
Phase 4 2No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular InterventionRecruitingNCT06909565Phase 4
- Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart DiseaseCompletedNCT01884545Not applicableResults posted
- Stress Management and Biomarkers of Risk in Cardiac RehabilitationCompletedNCT00981253Not applicableResults posted
- Responses of Myocardial Ischemia to Escitalopram TreatmentCompletedNCT00574847Phase 4Results posted
- An mHealth Intervention to Improve Medication Adherence and Health OutcomesCompletedNCT04703439Not applicable
- VIDA Mobile Health Cardiovascular Prevention ProgramCompletedNCT02431546Not applicable
- Patient and Provider Assessment of Lipid Management RegistryCompletedNCT02341664
- Patient-Reported Preferences Affecting Revascularization DecisionsCompletedNCT02272062Not applicable
- Care Transitions for Complex Patient - Cycle 1 and Cycle 2CompletedNCT01039324Not applicable
- Determination of the Prevalence and Prognostic Importance of Unrecognized Non-Q-wave Myocardial Infarction by MRICompletedNCT00493168